About: Kosan Biosciences     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:WikicatOrganizationsEstablishedIn1995, within Data Space : dbpedia.org associated with source document(s)
QRcode icon
http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FKosan_Biosciences

Kosan Biosciences, Inc. (stock symbol: KOSN), is a pharmaceutical company which deals with cancer therapeutics medications. The company is currently working on advancing two new classes of anticancer agents through clinical development: heat shock protein 90 (Hsp90) inhibitors and epothilones. Founded in 1995, Kosan is headquartered in Hayward, California and currently has approximately 90 employees. Kosan was funded in part as a venture capital start-up with funds from Sofinnova Ventures of California. On June 26, 2008, Kosan Biosciences was acquired by Bristol-Myers Squibb.

AttributesValues
rdf:type
rdfs:label
  • Kosan Biosciences
rdfs:comment
  • Kosan Biosciences, Inc. (stock symbol: KOSN), is a pharmaceutical company which deals with cancer therapeutics medications. The company is currently working on advancing two new classes of anticancer agents through clinical development: heat shock protein 90 (Hsp90) inhibitors and epothilones. Founded in 1995, Kosan is headquartered in Hayward, California and currently has approximately 90 employees. Kosan was funded in part as a venture capital start-up with funds from Sofinnova Ventures of California. On June 26, 2008, Kosan Biosciences was acquired by Bristol-Myers Squibb.
sameAs
dct:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
Link from a Wikipage to an external page
foaf:isPrimaryTopicOf
prov:wasDerivedFrom
has abstract
  • Kosan Biosciences, Inc. (stock symbol: KOSN), is a pharmaceutical company which deals with cancer therapeutics medications. The company is currently working on advancing two new classes of anticancer agents through clinical development: heat shock protein 90 (Hsp90) inhibitors and epothilones. Their technology platform is based on manipulation of the genetic instructions of microbes for making natural product polyketides. Rearranging the modular units in natural polyketide synthases, combining modules from different enzymes, and incorporating novel synthetic chemical starter units enables them to produce a wide variety of novel polyketides that would be difficult to obtain via organic synthesis alone. Founded in 1995, Kosan is headquartered in Hayward, California and currently has approximately 90 employees. Kosan was funded in part as a venture capital start-up with funds from Sofinnova Ventures of California. On June 26, 2008, Kosan Biosciences was acquired by Bristol-Myers Squibb.
http://purl.org/voc/vrank#hasRank
is Link from a Wikipage to another Wikipage of
is Wikipage disambiguates of
is foaf:primaryTopic of
Faceted Search & Find service v1.17_git39 as of Aug 09 2019


Alternative Linked Data Documents: PivotViewer | iSPARQL | ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3235 as of Jun 25 2020, on Linux (x86_64-generic-linux-glibc25), Single-Server Edition (61 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2020 OpenLink Software